Pay in 4 interest-free payments of $7.23 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Studies including SURPASS-3 with kidney outcomes show modest sodium excretion changes
Individuals with significant nutritional deficiencies may experience blunted responses
Those animal study findings are what prompted the boxed warning on Ozempic, Wegovy, and Rybelsus
The CFO, CLO, and CCO sold some of this stock by exercising options that didnt expire until the 2030s as well as shares related to recently vested restricted stock units
US$ 25.44
US$ 26.59
US$ 24.95
US$ 22.87
US$ 28.98
